These recommendations relate to a wide range of topics that the Taskforce believe would have a positive impact on tackling the drug problem faced in Scotland and ultimately save lives
Bibliography: Interventions – Harm Reduction
Injecting equipment provision in Scotland
Includes the number of outlets, attendances and the types of injecting equipment distributed to people who inject illicit drugs (including Novel Psychoactive Substances and Image and Performance Enhancing Drugs) in Scotland in 2020/21 (Public Health Scotland)
Effective practice guide Substance misuse
Based on: a joint thematic inspection of community-based drug treatment and recovery work with people on probation (HM Inspector of Probation)
Report of the Emerging Drug Trends and Drug Checking Working Group 2021
Report prepared for Minister of State for Public Health, Wellbeing and National Drugs Strategy by the HSE National Social Inclusion (Ireland)
New report highlights public health and social risks posed by synthetic cannabinoids in Europe
Synthetic cannabinoids come under the spotlight today in a new report released by the EU drugs agency (EMCDDA)
A Strategic Framework to Tackle the Harm from Substance Use (2021-31)
This strategy sets out our proposals for tackling the harms caused by substance use over the next ten years (DoH, Ireland)
Drug Law Reform Report
It explores how existing legislation and its use impacts on the current situation amid the changing landscape of Scotland’s unique drug deaths challenge (Scottish Drug Deaths Taskforce)
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study Wave 4
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
NIN on drug health harms briefing – May 2021
This briefing summarises the topics covered at the May 2021 meeting of the national intelligence network (NIN) on the health harms associated with drug use, with updated information where appropriate (Public Health England)
Focused Policy Assessment of Reducing Harm, Supporting Recovery
An analysis of expenditure and performance in the area of drug and alcohol misuse (Government of Ireland)
People who inject drugs: HIV and viral hepatitis monitoring
Data tables and commentary for the unlinked anonymous monitoring surveys of infections and risk among people who inject drugs (Public Health England)
Canadian Opioid Use Disorder Guideline
Opioid Agonist Therapy: A Synthesis of Canadian Guidelines for Treating Opioid Use Disorder is a national clinical guideline that harmonizes existing provincial and national guidelines, evidence-based practices and expert opinions into one document aimed at providing consistent and high-quality care to people with opioid use disorder (camh)
Report detailing the work and further progress of the Drug Deaths Taskforce
Summarising its work in terms of innovation projects, research projects, and interventions through ADP direct funding under the categories of Emergency Response, Reducing Risk and Reducing Vulnerability, the Report offers an appraisal of how and when these will impact ( Scottish Drug Deaths Taskforce)
The Harms of Incarceration
The evidence base and human rights framework for decarceration and harm reduction in prisons – Prisons Briefing (Harm Reduction International)
Trends in, and characteristics associated with, trouble accessing sterile needles and syringes among people who inject drugs in Sydney, New South Wales
This bulletin highlights the percentage of participants amongst a sample of people who regularly inject drugs in Sydney, NSW who reported having trouble accessing sterile needles in the past month, from 2011-2019 (NDARC)
Successful ‘click and deliver’ naloxone service delivers lifesaving kits in the post to reduce drug-related deaths
Scottish Families Affected by Alcohol and Drugs (Scottish Families) has issued 348 naloxone kits in its first year of running its online ‘click and deliver’ service. People order online and receive their lifesaving kit in the post a few days later
Public Health England: ‘Preventable bacterial infections remain a problem’
Bacterial infections may be less likely to make the headlines than fatal overdoses and blood-borne viruses, but they are a source of considerable suffering among people who inject drugs (SSA)
Failure To Fund
The continued crisis for harm reduction funding in low- and middle-income countries download (HRI)
Who’s more likely to be able to get naloxone (Narcan) at their pharmacy?
A look at the socioeconomic factors associated with naloxone availability (Recovery Research Institute)
Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons
The results from this study provide a first glimpse into new developments emerging both during and in response to the pandemic, and which could have important implications for the future (EMCDDA)
HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder
The Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder exempt eligible physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives from federal certification requirements related to training, counseling and other ancillary services that are part of the process for obtaining a waiver to treat up to 30 patients with buprenorphine (SAMHSA)
Death Penalty For Drug Offences: Global Overview 2020
This report, our tenth on the subject, continues our work of providing regular updates on legislative, policy and practical developments related to the use of capital punishment for drug offences, a practice which is a clear violation of international law (Harm Reduction International)
Independent report Crime and policing
Includes Drivers of stop and search activity (b): tackling drug-related crime (Commission on Race and Ethnic Disparities)
Civil Society Monitoring of Harm Reduction in Europe, 2020
The purpose of this report is to enrich the information and knowledge base of harm reduction interventions in Europe from the viewpoint of civil society organisations. We believe that this approach is a necessary, and useful, contribution to the development of drug policy in the region (Correlation Harm Reduction Network, The Netherlands)
Medication Assisted Treatment
MAT Standards for Scotland (Scottish Drugs Death Taskforce)
Drug control policies in Eastern Europe and Central Asia
The economic, health and social impact (Economist Intelligence Unit)
A state policy option to expanding access to methadone: Utilize Federally Qualified Health Centers
A state policy option to expanding access to methadone: Utilize Federally Qualified Health Centers (Recovery Research Institute)
Doing more harm than good
International examples of success, growing public support and the clear failure of current laws to stop drug use means the time is right now for drug law reform (Australian Lawyers Alliance)
Syringe Distribution Programs Can Improve Public Health During the Opioid Overdose Crisis
Such initiatives can reduce overdose rates and infectious disease, increase use of treatment (PEW)
College publishes report on drug-related deaths in Scotland
The Royal College of Physicians of Edinburgh (“the College”) has launched a new report on drug-related deaths in Scotland, based on the views of leading experts
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study Wave 3
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
Maximising access to drug treatment while minimising diversion of medications
A new EMCDDA report looks at striking the balance
Understanding high death rates of people with multiple and complex needs
Many people experiencing homelessness, drug and alcohol problems, mental ill health, and repeat offending die early as they become desensitised to death through suffering vast loss and lack of hope, new research has revealed (Fuse, the Centre for Translational Research in Public Health)
Government of Canada supports four safer drug supply projects in British Columbia
Life-saving initiatives will provide pharmaceutical-grade medication as alternative to toxic illegal drug supply during COVID-19 outbreak and beyond (Government of Canada)
ICER Publishes Final Evidence Report and Policy Recommendations for Supervised Injection Facilities
The Institute for Clinical and Economic Review (ICER) today released a Final Evidence Report and Report-at-a-Glance assessing the comparative clinical effectiveness and value of supervised injection facilities (SIFs), as a means to reduce harm among people who inject drugs
A Supplemental Report on British Columbia’s Unregulated Drug Supply Amidst Dual Public Health Emergencies
Results from British Columbia’s Community Drug Checking Service January 2020 – October 2020
Assessment of the harms of gamma-hydroxybutyric acid, gamma-butyrolactone, and closely related compounds
This report provides an updated harms assessment of gamma-hydroxybutyric acid (GHB) and related substances (ACMD)
Supervised Injection Facilities and Other Supervised Consumption Sites: Effectiveness and Value
The purpose of this assessment is to evaluate the health and economic outcomes of a Supervised Injection Facility. This review seeks to answer the question: What is the net health benefit of implementing a SIF (which includes an SSP) versus an SSP alone? (ICER)
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study Wave 2
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
Preliminary patterns in circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic
This report describes the preliminary patterns in circumstances surrounding opioid-related deaths in Ontario during COVID-19. An understanding of these circumstances is urgently needed to inform interventions and policies to prevent further opioid-related mortality in the midst of this pandemic (The Ontario drug policy research network)
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 12
- Next Page »
